Effects of neprilysin and neprilysin inhibitors on glucose homeostasis: Controversial points and a p...
Effects of neprilysin and neprilysin inhibitors on glucose homeostasis: Controversial points and a promising arena
About this item
Full title
Author / Creator
Publisher
Australia: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Australia: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Neprilysin (NEP) is a transmembrane zinc-dependent metalloproteinase that inactivates various peptide hormones including glucagon-like peptide 1 (GLP-1). NEP inhibitors may be effective in the management of type 2 diabetes mellitus (T2DM) by increasing the circulating level of GLP-1. However, acute-effect NEP inhibitors may lead to detrimental effe...
Alternative Titles
Full title
Effects of neprilysin and neprilysin inhibitors on glucose homeostasis: Controversial points and a promising arena
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10172023
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10172023
Other Identifiers
ISSN
1753-0393
E-ISSN
1753-0407
DOI
10.1111/1753-0407.13389
